- Home
- PPSI vs SCLX Comparison
PPSI vs SCLX Comparison
Compare PPSI & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- SCLX
- Stock Information
- Founded
- PPSI 2008
- SCLX 2011
- Country
- PPSI United States
- SCLX United States
- Employees
- PPSI N/A
- SCLX N/A
- Industry
- PPSI Electrical Products
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- SCLX Health Care
- Exchange
- PPSI Nasdaq
- SCLX Nasdaq
- Market Cap
- PPSI 30.0M
- SCLX 28.4M
- IPO Year
- PPSI N/A
- SCLX N/A
- Fundamental
- Price
- PPSI $2.68
- SCLX $5.12
- Analyst Decision
- PPSI Strong Buy
- SCLX Strong Buy
- Analyst Count
- PPSI 1
- SCLX 4
- Target Price
- PPSI $12.00
- SCLX $396.67
- AVG Volume (30 Days)
- PPSI 57.5K
- SCLX 146.9K
- Earning Date
- PPSI 05-15-2025
- SCLX 05-14-2025
- Dividend Yield
- PPSI 55.97%
- SCLX N/A
- EPS Growth
- PPSI N/A
- SCLX N/A
- EPS
- PPSI 2.84
- SCLX N/A
- Revenue
- PPSI $26,304,000.00
- SCLX $50,710,000.00
- Revenue This Year
- PPSI $23.90
- SCLX $115.30
- Revenue Next Year
- PPSI $19.35
- SCLX $73.33
- P/E Ratio
- PPSI $0.93
- SCLX N/A
- Revenue Growth
- PPSI 439.46
- SCLX 7.79
- 52 Week Low
- PPSI $2.25
- SCLX $3.60
- 52 Week High
- PPSI $7.00
- SCLX $80.50
- Technical
- Relative Strength Index (RSI)
- PPSI 48.06
- SCLX 48.72
- Support Level
- PPSI $2.61
- SCLX $4.43
- Resistance Level
- PPSI $2.89
- SCLX $5.94
- Average True Range (ATR)
- PPSI 0.21
- SCLX 0.54
- MACD
- PPSI 0.00
- SCLX 0.25
- Stochastic Oscillator
- PPSI 31.88
- SCLX 59.41
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.